WEIGHT loss jabs could raise the risk of a “potentially blinding condition” known as an “eye stroke”, researchers have warned ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

In recent months, the efficacy of contraception for people taking weight loss medications has been questioned, as several women claim to have gotten pregnant despite using oral contraceptives.

Four years after starting semaglutide, patients maintained an average weight loss of 10% of their body ... doctors say more long-term data is needed before committing patients to this drug for ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...